How much should you hold?
- Overall Portfolio exposure to SANUWAVE Health, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
74.79%
EBIT Growth (5y)
20.23%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
42.75%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-18.15
EV to EBIT
39.06
EV to EBITDA
33.43
EV to Capital Employed
77.47
EV to Sales
7.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
198.32%
ROE (Latest)
Negative BV
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
33What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 1.29 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 11.07 times
RAW MATERIAL COST(Y)
Fallen by -3.73% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -506.62 %
NET SALES(Q)
Highest at USD 11.45 MM
PRE-TAX PROFIT(Q)
Highest at USD 4.9 MM
NET PROFIT(Q)
Highest at USD 4.9 MM
EPS(Q)
Highest at USD 0.46
-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.91 times
Here's what is working for SANUWAVE Health, Inc.
Pre-Tax Profit
At USD 4.9 MM has Grown at 859.84%
over average net sales of the previous four periods of USD -0.64 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 4.9 MM has Grown at 851.98%
over average net sales of the previous four periods of USD -0.65 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 1.29 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Highest at 11.07 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
Highest at USD 11.45 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 11.45 MM has Grown at 16.87%
over average net sales of the previous four periods of USD 9.8 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Pre-Tax Profit
Highest at USD 4.9 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 4.9 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.46
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at -506.62 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -3.73% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for SANUWAVE Health, Inc.
Inventory Turnover Ratio
Lowest at 1.91 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






